ClinicalTrialPipelineDrugCostSharingPriorAuthorizationValue-BasedCareCopayHealthPlanSpecialtyDrugBrand-NameDrugStepTherapyPharmacyBenefitClaimsDataNon-PreferredDrugMedicalBenefitGenericDrugReal-WorldEvidenceFormularyMarketAccessBiosimilarUtilizationManagementPharmacyBenefitManager(PBM)RebateHealthEconomicsand OutcomesResearch(HEOR)NetworkPharmacyP&TCommitteeOut-of-PocketCostTieredFormularyMail-OrderPharmacyFDAApprovalPreferredDrugAdherenceIndicationClinicalTrialPipelineDrugCostSharingPriorAuthorizationValue-BasedCareCopayHealthPlanSpecialtyDrugBrand-NameDrugStepTherapyPharmacyBenefitClaimsDataNon-PreferredDrugMedicalBenefitGenericDrugReal-WorldEvidenceFormularyMarketAccessBiosimilarUtilizationManagementPharmacyBenefitManager(PBM)RebateHealthEconomicsand OutcomesResearch(HEOR)NetworkPharmacyP&TCommitteeOut-of-PocketCostTieredFormularyMail-OrderPharmacyFDAApprovalPreferredDrugAdherenceIndication

GBM 1: Managed Care Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
  1. Clinical Trial
  2. Pipeline Drug
  3. Cost Sharing
  4. Prior Authorization
  5. Value-Based Care
  6. Copay
  7. Health Plan
  8. Specialty Drug
  9. Brand-Name Drug
  10. Step Therapy
  11. Pharmacy Benefit
  12. Claims Data
  13. Non-Preferred Drug
  14. Medical Benefit
  15. Generic Drug
  16. Real-World Evidence
  17. Formulary
  18. Market Access
  19. Biosimilar
  20. Utilization Management
  21. Pharmacy Benefit Manager (PBM)
  22. Rebate
  23. Health Economics and Outcomes Research (HEOR)
  24. Network Pharmacy
  25. P&T Committee
  26. Out-of-Pocket Cost
  27. Tiered Formulary
  28. Mail-Order Pharmacy
  29. FDA Approval
  30. Preferred Drug
  31. Adherence
  32. Indication